EP3307241
Drjúpanlegt tvímatóprost augngel
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.6.2016EP published:
26.9.2018EP application number:
16729525.2
EP translation filed:
29.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
7.6.2036Expiry date:
7.6.2026Next due date:
30.6.2026
Title:
DRIPPABLE OPHTHALMIC BIMATOPROST GEL
Timeline
Today
8.6.2016EP application
26.9.2018EP Publication
29.10.2018Translation submitted
15.11.2018Registration published
7.6.2026Expires
Owner
Name:
MEDproject Pharma-Enwicklungs- und Vertriebsgesellschaft mbHAddress:
Bajuwarenring 14, 82041, Oberhaching, DE
Inventor
Name:
POLZER, HeinzAddress:
Weißensberg, DE
Name:
ELENA, Pierre-PaulAddress:
Nice, FR
Name:
SENGE, JürgenAddress:
München, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15171233Date:
9.6.2015Country:
EP
Classification
Categories:
A61K 9/06, A61K 47/10, A61K 47/32, A61K 31/5575, A61P 27/06
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 3.6.2019
Expires: 7.6.2020
Payer: Árnason Faktor
Number: 5
Paid: 3.6.2020
Expires: 7.6.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 25.5.2021
Expires: 7.6.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.5.2022
Expires: 7.6.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.6.2023
Expires: 7.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.6.2024
Expires: 7.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 2.6.2025
Expires: 7.6.2026
Payer: Árnason Faktor ehf.